LIGAND PHARMACEUTICALS INC — Director's Dealing 2012

May 24, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2012-05-23

Reporting Person: Patel Sunil (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-23	Common Stock	P	100.0	$11.348	Acquired	28305.0	Direct
2012-05-23	Common Stock	P	100.0	$11.35	Acquired	28405.0	Direct
2012-05-23	Common Stock	P	20.0	$11.348	Acquired	28425.0	Direct
2012-05-23	Common Stock	P	31.0	$11.37	Acquired	28456.0	Direct
2012-05-23	Common Stock	P	1249.0	$11.386	Acquired	29705.0	Direct